Searched over 200M research papers
10 papers analyzed
These studies suggest the lowest effective dose of losartan for children is 0.75 mg/kg (maximum 50 mg).
20 papers analyzed
Losartan, an angiotensin II receptor blocker (ARB), is widely used to manage hypertension, heart failure, and certain kidney diseases. Determining the lowest effective dose is crucial for minimizing side effects while maintaining therapeutic efficacy.
A study on hypertensive children aged 6 to 16 years evaluated the dose-response relationship of losartan ranging from 2.5 mg to 100 mg. The results indicated that a starting dose of 0.75 mg/kg (up to a maximum of 50 mg) effectively reduced diastolic blood pressure (DBP) within three weeks. Higher doses up to 1.44 mg/kg (maximum 100 mg) were well tolerated and provided additional blood pressure reduction.
In younger children aged 6 months to 6 years, losartan was administered at doses of 0.1 mg/kg, 0.3 mg/kg, and 0.7 mg/kg per day. The study found significant reductions in systolic blood pressure (SBP) and DBP across all doses, but no clear dose-response relationship was established. The maximum dose used was 1.4 mg/kg per day, which was well tolerated.
A study on normotensive patients with IgA nephropathy demonstrated that a low dose of losartan (12.5 mg/day) significantly reduced proteinuria over 12 months without affecting systemic blood pressure. This suggests that even at low doses, losartan can provide renal protective effects.
The HEAAL study compared high-dose (150 mg) and low-dose (50 mg) losartan in patients with heart failure. The high-dose group showed a reduced rate of death or hospital admission for heart failure compared to the low-dose group. However, higher doses were associated with increased adverse events such as renal impairment and hyperkalemia.
Pharmacokinetic studies indicate that losartan is rapidly absorbed and converted to its active metabolite, EXP3174, which is more potent. The standard recommended dose is 50 mg/day, but evidence suggests that higher doses (up to 100 mg/day) may provide greater clinical benefits .
The lowest effective dose of losartan varies depending on the patient population and condition being treated. In hypertensive children, doses as low as 0.75 mg/kg are effective, while in normotensive patients with IgA nephropathy, 12.5 mg/day can reduce proteinuria. For heart failure, higher doses (150 mg) may offer better outcomes but with increased risk of adverse events. Overall, losartan is effective and well-tolerated across a range of doses, but the optimal dose should be tailored to individual patient needs and conditions.
Most relevant research papers on this topic